Labor Induction News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Labor induction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Labor Induction Today - Breaking & Trending Today

Karolinska Development's portfolio company Dilafor presents positive results from a phase 2b study of tafoxiparin

STOCKHOLM, SWEDEN 1 June 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the portfolio company Dilafor has concluded a phase 2b study with its drug candidate tafoxiparin which showed a significant positive impact on cervical ripening in first-time mothers receiving treatment to induce labor. Further and full analysis of data will be done by the company. Market analyses show that a drug that can induce cervical ripening has the potential to reach annual sales in excess of USD 1 billion in the US market alone. Karolinska Development will obtain an external assessment of how the positive study results affect the book value of its holding in Dilafor. About a quarter of all pregnant women are subject to labor induction, however more than half of these experience failed induction. This leads to a prolonged birth process that increases the need for a caesarean section and the risk of complications in both mother and child. Dilafors' double-blind, placebo-con ....

Karolinska Development Ab , Cervical Ripening , Study Results , Karolinska Development , Drug Candidate , Labor Induction , Nasdaq Stockholm , Phase 2b ,